A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and
Clinical Trial Grant
Awarded By
Takeda Pharmaceutical Company Limited
Start Date
February 5, 2021
End Date
June 29, 2022
Awarded By
Takeda Pharmaceutical Company Limited
Start Date
February 5, 2021
End Date
June 29, 2022